Figure 2
MIC of cefiderocol according to mechanism of resistance. Dotted line represents EUCAST 2023 clinical breakpoint of cefiderocol (susceptible, MIC ≤ 2 mg/L).
Figure 2 | Scientific Reports
MIC of cefiderocol according to mechanism of resistance. Dotted line represents EUCAST 2023 clinical breakpoint of cefiderocol (susceptible, MIC ≤ 2 mg/L).
